![The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-021-93435-x/MediaObjects/41598_2021_93435_Fig2_HTML.png)
The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports
![Hepatic steatosis on FibroScan with controlled attenuation parameter... | Download Scientific Diagram Hepatic steatosis on FibroScan with controlled attenuation parameter... | Download Scientific Diagram](https://www.researchgate.net/publication/339994413/figure/fig1/AS:870246873317377@1584494431520/Hepatic-steatosis-on-FibroScan-with-controlled-attenuation-parameter-CAP-S0-CAP-233.png)
Hepatic steatosis on FibroScan with controlled attenuation parameter... | Download Scientific Diagram
![FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study - The Lancet Gastroenterology & Hepatology FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/attachment/30b3a6ab-da44-4a85-aa46-5cbc9fc28cc8/gr1_lrg.gif)
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study - The Lancet Gastroenterology & Hepatology
![Diagnostics | Free Full-Text | Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan Diagnostics | Free Full-Text | Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan](https://pub.mdpi-res.com/diagnostics/diagnostics-10-00159/article_deploy/html/images/diagnostics-10-00159-g002.png?1585789611)
Diagnostics | Free Full-Text | Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan
![Assessment of Hepatic Steatosis in Patients with Chronic Hepatitis B Using Fibroscan and its Relation to Insulin Resistance Assessment of Hepatic Steatosis in Patients with Chronic Hepatitis B Using Fibroscan and its Relation to Insulin Resistance](https://openbiomarkerjournal.com/contents/volumes/V9/TOBIOMJ-9-70/TOBIOMJ-9-70_F2.jpg)
Assessment of Hepatic Steatosis in Patients with Chronic Hepatitis B Using Fibroscan and its Relation to Insulin Resistance
![Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease - ScienceDirect Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0016508519301052-fx1.jpg)
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease - ScienceDirect
![JCM | Free Full-Text | Diagnostic Accuracy of Non-Imaging and Ultrasound-Based Assessment of Hepatic Steatosis Using Controlled Attenuation Parameter (CAP) as Reference JCM | Free Full-Text | Diagnostic Accuracy of Non-Imaging and Ultrasound-Based Assessment of Hepatic Steatosis Using Controlled Attenuation Parameter (CAP) as Reference](https://pub.mdpi-res.com/jcm/jcm-10-01507/article_deploy/html/images/jcm-10-01507-g004.png?1628054596)